Center for Global Health

Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost.

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti.

Researchers at Weill Cornell Medicine found that partnering with local religious leaders boosted adoption of family planning methods in Tanzania.

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

Collaborating with traditional healers to deliver point-of-care HIV tests to individuals in rural Uganda quadrupled testing rates compared with standard referrals to HIV clinics.

Gut bacteria play an important role in the body’s response to treatment for tuberculosis (TB), according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering.

As the epicenter of the COVID-19 pandemic moves to Latin America and Africa, Weill Cornell Medicine faculty based in Haiti, a country hard hit by natural disasters and poverty, have developed lessons on what low-resourced countries can do to address and treat the outbreak on the ground.

Dr. Michael G. Stewart, an esteemed clinician and leader, has been appointed senior associate dean for international affairs and affiliations and is leading both the Office of International Affairs and the Office of Affiliations, which manages the institution’s affiliations with academic medical centers and healthcare organizations nationwide.

Weill Cornell Medicine and GHESKIO have received a two-year $158,000 grant from LINKS to support the institutions’ work addressing high blood pressure in Haiti’s most vulnerable communities.

Dr. Kathryn Dupnik, an assistant professor of medicine at Weill Cornell Medicine, has been awarded a 2019 Clinical Scientist Development Award by the Doris Duke Charitable Foundation.

Despite comprising up to 80 percent of global health faculty members and workers, women hold only a fraction of global health leadership roles.

Dr. Jean William “Bill” Pape, the Howard and Carol Holtzmann Professor in Clinical Medicine and the founder and director of GHESKIO in Haiti, has been awarded the inaugural Joan and Sanford I. Weill Exemplary Achievement Award from Weill Cornell Medicine.

Dr. Daniel Fitzgerald, an international leader in infectious diseases, has been named director of the Center for Global Health at Weill Cornell Medicine.

One of the first groups of AIDS patients to receive free HIV drugs in a public health setting in the developing world are living as long as those in the United States.

The NIH has awarded Weill Cornell up to $45.7 million to fund a research collaboration dedicated to stopping tuberculosis from becoming progressively less treatable worldwide.